SURMOUNT-2 (NCT04657003) Study Title: "Tirzepatide Once Weekly for the Treatment of Obesity in People With Type 2 Diabetes" Status: Completed Phase: Phase 3 Enrollment: 938 participants Study Period: 2020-2022 Design: Randomized, double-blind, placebo-controlled Duration: 72 weeks Intervention: Tirzepatide 10/15 mg SC weekly vs
Efficacy of levo carnitine and alpha lipoic acid in ameliorating the decline in mitochondrial enzymes during aging
The medication is most effective when combined with sustainable lifestyle modifications rather than viewed as a standalone solution
Can a hair transplant fix shedding caused by weight loss
Chen G, Shu H, Chen G, Ward BD, Antuono PG, et al
its a commitment to a comprehensive, medically guided transformation